Genopliv ApS: Financial statements 2023
CVR: 43711172
Source: annual report 2023, Danish Business Authority
08/12/2022 – 31/12/2023
Genopliv ApS (CVR 43711172) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1,301,478 and a net result of DKK 491,818. Equity in the 2023 report amounted to DKK 531,818. The solvency ratio was 46.1%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,301,478
- Profit/Loss
- DKK 491,818
- Equity
- DKK 531,818
- Total Assets
- DKK 1,153,511
- Employees
- 1
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationAbout Genopliv ApS
Genopliv ApS is a Danish company of the type Anpartsselskab based in Holbæk, founded in 2022. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Kim Janos Pedersen. The company is owned by Kim Janos Pedersen. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 1,031,847 and a net result of DKK 117,485 compared with DKK 170,895 the year before. Equity in the 2025 report amounted to DKK 725,199.